Callouts & quotes from 536+ activist slides

"CFO Allais: "And while we're not providing 2022 guidance here, we currently expect OpenSlate to contribute between $15 million and $18 million of revenue in 2022." — OpenSlate Nov 2021; Barclays Analyst: "And then like M&A for you is more tuck-in, it's not like -- there's nothing transformational you can do there?" — Barclays Conf. Dec 2022; CEO Zagorski: "I just don't think we need to do transformational right now. We've got so much core growth to do right now. It sounds like how do we make it go faster." — Barclays Conf. Dec 2022; CFO Allais: "And I think that accelerates organic growth and just kind of continues our opportunity for what we are looking for." — Barclays Conf. Dec 2022"

"On May 17, 2020, the Company entered into a purchase agreement with the sole member of Smart2Pay, a payment services provider headquartered in The Netherlands, to acquire all of the sole member's ownership interest for total consideration of approximately $240,001 (€221,567). The total consideration is expected to be settled with a cash consideration of $66,689 (€61,567) and the remaining balance will be paid either by issuance of a convertible debenture of $173,312 (€160,000) or by the issuance of shares of the Company, for which a final determination has not yet been made. The closing of the transaction is subject to certain customary conditions. — Nuvei IPO Prospectus at Sedar.com"

"3M is offering me cases at a $500 lab fee compared to my Invisalign Lab fee of $1,000. If I can start doing more cases with 3M and it will save me money, why not just switch? 3M software is excellent. It is very easy to use. They brought a lot of people over from Invisalign. It’s getting to the point where it will be as good as Invisalign. — Orthodontist, Diamond Plus Align Tier; 3M came to me and said that we can do all of your cases for $600... I expect my Invisalign volumes to be down going forward — Orthodontist, Diamond Plus Align Tier; We are going to see major price compression with lab fees in the next one to two years. — Senior Employee, Major Dental Equipment Supplier"

"3M is offering me cases at a $500 lab fee compared to my Invisalign Lab fee of $1,000. If I can start doing more cases with 3M and it will save me money, why not just switch? 3M software is excellent. It is very easy to use. They brought a lot of people over from Invisalign. It's getting to the point where it will be as good as Invisalign. — Orthodontist, Diamond Plus Align Tier; 3M came to me and said that we can do all of your cases for $600... I expect my Invisalign volumes to be down going forward — Orthodontist, Diamond Plus Align Tier; We are going to see major price compression with lab fees in the next one to two years. — Senior Employee, Major Dental Equipment Supplier"

""Meredith said the first ground firing of a GEM-63 motor is scheduled for mid-2018, and the booster will be ready for Atlas 5 launches by the end of 2018." — Source; "In the fifth paragraph of a press release highlighting its "industry-leading strategic partnerships" for building Vulcan, the company announced it had selected Blue Origin's BE-4 engine for Vulcan, a choice nearly everyone expected." — Source; "Aerojet also produces the hydrogen-fueled RS-68 main engine for ULA's soon-to-retire Delta 4 rocket and still hopes to convince ULA to use the kerosene-fueled AR1 for Vulcan's main stage (ULA, however, has said the lead contender is Blue Origin's BE-4 engine)." — Source"

""The timing just worked very well for us right now. K2M has really developed stronger and stronger performance with their new product launches. So the timing just came together right now.... And so I'm very optimistic about the 2 organizations merging very well and performing very well." — Stryker CEO Lobo, Q3 2018 Conf Call. "We expect mid-single-digit performance on a pro forma basis. And then obviously, in 2020, that'll then roll into organic. So we're really excited with the speed of that integration and being able to post these numbers with a Spine business that's been essentially flat for the past 5 years is pretty remarkable." — Stryker CEO Lobo, Q4 2018 Conf Call."

""From then on, we believe that after this has been worked through, the market is going to grow with around 6.8% on average and we're going to grow as you saw by our gains in the marketplace or by our market share gains, we got to grow above that." — Dr. Klaus Kleinfeld, February 8, 2017; "On Engineered Products and Solutions, we expect the revenues to be up low single digits driven by share gains of new aero platforms..." — Dr. Klaus Kleinfeld, January 31, 2017; "I want to show you and demonstrate how we can gain market share with those innovative products and how we can grow with those products..." — Karl Tragl, Group President – EPS at Arconic, December 14, 2016"

""So about 4 years ago, we launched a workflow solution in partnership with IBM. And the great thing is that workflow solution exceeded our expectations in terms of the amount of customer demand for Box having workflow as a kind of core capability. The challenge was that the functionality, the user experience was separate from the core Box experience because it was sold as a joint offering. And so we made the evaluation with IBM that it probably made more sense for that to be a native capability within Box. And so about 1.5 years ago, we went down the path of re-architecting the solution. We acquired a company as a tuck-in acquisition." — Aaron Levie, March 2020"

""Based on conversations with investors, we think the market believes that TCO is spending $500M, or 100% of the total expected investment in Beverly Center, to merely preserve 2015 NOI when the project stabilizes in 2020." — KeyBanc, March 11, 2016; "Yet Another Low Development Yield at Beverly Center" — UBS, March 8, 2016; "Yield and IRR Forecasts Paint A Foggy Picture" — UBS, March 8, 2016; "What's most puzzling is why the company did not address the capex/redevelopment needs of the asset earlier knowing that Century City went through a prior redevelopment in 2007 that led to a gradual market share loss for Beverly Center...." — Evercore ISI, March 10, 2016"

""I would say the founders and Peter Chapman knowing what I know." — Former senior scientific employee of IonQ; "...the statements that are being made, I do not believe, are consistent with the capabilities that they have and what they can potentially deliver is the concern... I don't think there's much harm in those. But if you're making outlandish claims that are in a sense so far removed from what can actually be done with what is available today and what can realistically be expected based on know-how and technical understanding of how our system currently behaves, then this can actually be very discouraging." — Former senior scientific employee of IonQ"

"“We are very focused on bending our cost down again in 2024.” — CFO Tammy Romo; “We've got a lot of opportunity to now go work on bringing out inefficiencies...” — CEO Bob Jordan; “As we look ahead to next year, we are absolutely committed to driving our unit cost down.” — CFO Tammy Romo; “Our [FY'24] CASMx guidance of a 6% to 7% increase year-over-year is also essentially driven by labor and maintenance cost pressures...” — CFO Tammy Romo; “[We expect] our full year CASM-X to increase in the range of 7% to 8% year-over-year, elevated from our previous full year CASM-X guidance due to lower capacity plans in the second half of the year.” — CFO Tammy Romo"

"“There were certain revenue expectations that the company had, that Ginkgo had for [key related party name redacted], and a certain timeline to achieve those. ... there was real pressure to produce, to do work in the Ginkgo foundry to produce revenue in their foundry that would have no real value for [key related party name redacted]. It was sort of make work because there was an expectation that that work needed to be done. Like I balked at that, basically, and was like, I can't do that. I'm not working for Ginkgo; it's not in the best interest. We have to take two steps back and think this through. I kind of got axed for that.” — Former Ginkgo employee"

""We are very focused on bending our cost down again in 2024." — CFO Tammy Romo; "We've got a lot of opportunity to now go work on bringing out inefficiencies..." — CEO Bob Jordan; "As we look ahead to next year, we are absolutely committed to driving our unit cost down." — CFO Tammy Romo; "Our [FY'24] CASMx guidance of a 6% to 7% increase year-over-year is also essentially driven by labor and maintenance cost pressures..." — CFO Tammy Romo; "[We expect] our full year CASM-X to increase in the range of 7% to 8% year-over-year, elevated from our previous full year CASM-X guidance due to lower capacity plans in the second half of the year." — CFO Tammy Romo"

""They're both high-single-digit growers upper extremity and lower extremely, accretive to overall Stryker's organic growth." — Spencer Response, Wright Medical Deal Call, November 4, 2019. "As it relates to sales expectations for Wright Medical, we now expect comparable growth for trauma and extremities to be in the mid-single digits for the full year when compared to the combined results for 2019." — CFO Boehnlein, FY 2020 Conf Call, Jan 2021 and Q1 2021 Conf Call, April 2021. "And we sort of moved it up to mid-single, and now we're kind of thinking it's really going to be 6-plus percent for this year." — Spencer Response, Q2 2021 Conf Call, July 2021."

"In addition to the accelerated growth we anticipate from PDGM disruption in the marketplace that Keith discussed earlier, another significant incremental organic growth opportunity as we head into 2020 is, of course, our expected admissions acceleration from the Almost Family locations. In the 130 Almost Family locations fully converted to LHC Group's instance of Homecare Homebase prior to the third quarter, we demonstrated sequential organic growth in home health admissions of 1.2% in the quarter as compared to the second quarter despite the fact that Q3 is typically a seasonally lower volume quarter than Q2. — Joshua Proffitt - CFO & Treasurer, LHCG"

"It has recently closed the purchase of several plots of commercial real estate in the Economics Development Area of Zhengzhou, Henan Province, for a total consideration of RMB333.8 million. GSX has made the first installment payment of RMB69 million, and expect to complete the payment of the remaining installments within the next 3 years. Such commercial real estate includes two completed office buildings and one office building in construction. GSX plans to use these premises for business operating functions. They expect to begin business operations in these office buildings in the second half of 2020. — GSX Techedu (January 31, 2020 announcement)"

"That is very concerning. We use this drug to make blood sugars go up...we've talked about theoretically, the hypoglycemic effect, because we use this drug all the time, we're the biggest referral center for hyperinsulinism in little babies...we also talked about it being a little surprising because we weren't expecting this to be the type of drug that would be used in this condition...people seem to say, okay, we'll see...certainly at the meeting, I didn't go to any specific talks about this, but no one talked about it. I don't think it was a big enough topic to make the headlines. — Pediatric oncologist, Children's Hospital of Philadelphia (CHOP)"

"“Thank you, Peter, and good afternoon, everyone. I would like to start off by quickly going through some of our financial results in more detail. Earlier in Q3, we raised our full year 2021 forecasted bookings expectations from $5 million to $15 million. Today, I am happy to announce that as of the end of Q3, our total bookings for the year have already exceeded our increased expectations for the full year ending up at $15.1 million. We believe this is a recognition of the promise our customers see in our platform, and resulted from customers buying more and also earlier than we had expected.” — CFO, IonQ Q3 2021 earnings call on Nov 15, 2021"

""I was just on -- in your appendix, you obviously showed that the raw material prices and talk about levels for palm oil and rapeseed oil that are unusually high... I'd be interested in your view as to how much is just kind of cyclical factors... versus maybe more structural factors" — Alexander Morrow, Barclays Bank PLC, Research Division. "So there's, call it, a bit of disturbance into the supply chain and supply... And then when you look at this going forward, there is an expectation that prices will come down, but that has been rolling a bit. So at the moment, we're moving -- we're sliding sideways." — Johan Westman, AAK President & CEO."

""Verint has done a great job getting their house in order, achieving solid growth in a tough IT spending environment. And now they do what I would view as a Picasso-like acquisition." — Daniel Ives (FBR Capital Markets) on KANA acquisition; "The acquisition is expected to create a comprehensive omni-channel cloud VoC portfolio by adding ForeSee's causal modeling, predictive analytics, and benchmarking to Verint's domain expertise in automation and analytics. We view the acquisition's rationale and valuation favorably and believe it adds to VRNT's recent solid fundamental performance." — Shaul Eyal (Oppenheimer & Co.) on ForeSee acquisition"

""Sales momentum increased during the last two weeks of April. This increase in traffic and orders has carried over into May so we expect this month’s orders could be in-line with last May." — Steven J. Hilton, CEO of Meritage Homes (NYSE: MTH). "Shelter-in-place has not impacted our ability to lease homes. In fact, residents have been moving into our portfolio at a similar rate to last year and at a greater rate than they have been moving out." — Dallas Tanner, CEO of INVH. "we expect something close to an exodus from these really large cities where housing is so expensive...search traffic has already shifted on our website." — Redfin"

""International is an area we made important progress during this quarter." — CEO Dudum on Q2 2021 Earnings Call; "In Q3, we expect Honest Health and Apostrophe to generate between $4 million to $5 million in revenue." — CFO Lee on Q2 2021 Earnings Call; "Its early days for Honest Health and Apostrophe and their businesses are in a fairly similar place, where we were a couple of years ago." — CFO Lee on Q2 2021 Earnings Call; "As we indicated on our previous earnings call, the quarter-over-quarter decrease in gross margin was primarily driven by lower margin revenue from Apostrophe and Honest Health." — CFO Lee on Q3 2021 Earnings Call"

""We believe that having an independent chair is the preferred structure for board leadership. Having an independent chair avoids the inherent conflict of self-oversight and helps ensure robust debate and diversity of thought in the boardroom." — Wellington; "The roles of chair and CEO are substantially different, requiring distinctly different skills and experience. Therefore, LGIM expects the two roles to be separated." — Legal & General; "Harris has an existing guideline that states that we will normally vote in favor of proposals requiring the separation of the Chairman and Chief Executive Officer positions" — Harris Associates."

""We believe that having an independent chair is the preferred structure for board leadership. Having an independent chair avoids the inherent conflict of self-oversight and helps ensure robust debate and diversity of thought in the boardroom." — Wellington; "The roles of chair and CEO are substantially different, requiring distinctly different skills and experience. Therefore, LGIM expects the two roles to be separated." — Legal & General; "Harris has an existing guideline that states that we will normally vote in favor of proposals requiring the separation of the Chairman and Chief Executive Officer positions" — Harris Associates"

""The purpose of these actions is to have the management of the company carry out their management duties with more consideration of cost of capital and profitability based on the balance sheet, rather than just sales and profit levels on the income statement, in order to achieve sustainable growth and increase corporate value over the mid- to long-term." ... "the management team is expected to take the lead in appropriately allocating resources with sufficient consideration of cost of capital and profitability..." — Action to Implement Management That Is Conscious of Cost of Capital and Stock Price – JPX Tokyo Stock Exchange"

"Oct 28, 2021: "And so as a result, we have seen some increased costs as well in terms of inflation on those items. But to date, our supply chain and procurement teams have really just been able to manage that." — Stryker CFO/IR. Jan 27, 2022: "we expect gross margin performance to be negatively impacted by 50 to 100 basis points with a more pronounced impact in the first half of the year." — Stryker CFO/IR. March 11, 2022: "it's going to lean more towards 100 basis points in the first half of the year and then it will moderate down as some of these supply chain issues improve in the back half of the year." — Stryker CFO/IR."

"Both Resideo and Snap One share a strong culture of innovation and employee bases dedicated to supporting their integrators and driving value in the markets where they operate. We see significant benefits for integrators in the combined businesses with a wider selection of third-party and proprietary products, access and enhancements to support services and rapid product fulfillment through a comprehensive branch footprint and strong digital capabilities. All of this creates an attractive financial profile that we expect to be accretive to revenue growth, margins and non-GAAP EPS for Resideo. — CEO Deal Call April 2024"

""The second year after close, we expect to achieve at minimum $175 million in cost synergies." — Biovail; "By the end of the fourth quarter [of 2011] we expect to achieve approximately $350 million synergy run rate for the Company." — Biovail; "We expect to realize annual run rate constant synergies of greater than $225 million." — Medicis; "We now expect to achieve greater than $300 million in run rate synergies by the end of the year [2013]." — Medicis; "We expect to achieve at least $800 million in annual cost savings." — Bausch + Lomb; "We have now identified greater than $900 million in synergies" — Bausch + Lomb"

"They [Kratos] could never pay their bills during the time I was there. Terms were net 90 for every vendor expect ones like SDG&E, etc. It was stressful because of this, causing non stop credit holds, non stop emails from vendors wanting payment, statements to review that had months of bills entered but not paid. I couldn't wait to leave. The office supply area was completely bare and empty. It was hard to order supplies. Many temps would buy their own supplies and bring them in. Supplies such as inboxes, file folders, etc, that should have ben provided by the company — Accounts Payable Specialist, Glassdoor Review"

""No incremental debt incurred in acquisition" — TROX presentation – slide 15, 10/6/11; "Future cash flow from operations expected to be sufficient to pay cash portion of merger consideration ($12.50 per share or ~$190 million in aggregate)" — TROX presentation – slide 15, 10/6/11; "We've announced that we intend to issue dividends that are consistent with the industry peers. But with this level of free cash flow generation, there will also be opportunities for return of additional cash above and beyond the dividend to shareholders, and we will be exploring those alternatives." — TROX conference call – 10/10/11"

"(6) our belief that our competitive advantage is largely attributable to the technical, marketing, and sales competence and capabilities of our employees, rather than on any individual trademark and; (18) our belief that we are starting 2023 with a strong foundation and demand for our business remains strong; (19) our belief that strategic pricing efforts helped offset inflationary pressures we experienced in fleet, material and other people associated cost and our expectations to pull forward our price increase again in 2023 and raise prices for services in the first quarter; — Rollins Inc. 2022 and 2021 10-K"

""Because CAR-T is a personalized therapy, the launch of the product is likely to be limited by (a) the medical centers which can administer the therapy and (b) the complex manufacturing process...we would expect initial revenues in the hundreds of millions, not the billions." — Morgan Stanley, August 2017. "Now both KISQALI and KYMRIAH have had slower starts, but we remain confident that with KISQALI, over time, we can build this into a blockbuster medicine...and with KYMRIAH...we feel confident...we can drive KYMRIAH's growth well into the future." — Vasant Narasimhan, CEO of Novartis, Q4 2018 Earnings Call."

"“Our ending inventory balance was $200 million, in line with our expectations and up from $98 million a year ago. The difference is primarily a combination of three things: first, as we've said in the past few quarters, we continue to build back our inventory levels to support strong consumer demand; second, our consolidated results now include Naturium, which added approximately $26 million of inventory; lastly, an additional $23 million of the increase as a result of taking ownership of inventory from China when it ships versus when it enters our distribution center here in the U.S.” — Mandy Fields, ELF CFO"

"“...The very important message here is, there is value creation here, both for the owner of the stores, the parkings and I think where new activity is created, this is us and there is value creation as well from Mercialys. So the message here is we expect these renovations to continue and we expect to generate some profits from these projects in the future as well. I think in the interest of the investor community, we might organize, together with Régine and the team of Mercialys, a site visit so people realize that this is not financial engineering...” — 15 October 2015 Casino Q3 Sales/Trading Statement Call"

""To generate the large amount of private capital required to fund such a system, the Guarantor business model and expected returns through the cycle need to be attractive. That is, private investors in the Guarantors would have a reasonable expectation of a market rate of return on a risk-adjusted basis. To achieve this objective, investors would want to ensure that capital requirements are not too high, regulation and supervision is not too expensive, credit standards are sound and efforts to make housing more affordable do not impinge significantly on returns." — Mortgage Bankers Association, 4/20/2017"

"“To generate the large amount of private capital required to fund such a system, the Guarantor business model and expected returns through the cycle need to be attractive. That is, private investors in the Guarantors would have a reasonable expectation of a market rate of return on a risk-adjusted basis. To achieve this objective, investors would want to ensure that capital requirements are not too high, regulation and supervision is not too expensive, credit standards are sound and efforts to make housing more affordable do not impinge significantly on returns.” — Mortgage Bankers Association, 4/20/2017"

""Our ending inventory balance was $191 million, in line with our expectations and up from $81 million a year ago. The difference is primarily a combination of 3 things: first, as we've said the past few quarters, we continue to build back our inventory levels to support strong consumer demand. Second, our consolidated results now include Naturium, which added approximately $26 million of inventory; lastly, an additional $8 million of the increase is the result of taking ownership of inventory from China when it ships versus when it enters our distribution center here in the U.S." — Mandy Fields, ELF CFO"

"Mercury is building a C4I rugged server business. Mercury highlighted how its acquisition of Germane benefits from its FY18 acquisition of Themis, which the company views as a platform to build upon. The two entities have complementary rugger server portfolios and cover much of the C4I market with an expected ~$100 mn in revenue. Near-term, the Germane acquisition is dilutive to company-wide profitability but Mercury should achieve cost synergies after integrating the units and believes the combined entity will reach the midpoint of MRCY's adjusted EBITDA margin target in 2020 — JPMorgan July 2018"

"It is kind of a sham transaction, and that announcement was—for me, that bordered on bullshit—when they tripled revenue expectations because it was like, look, you just signed this deal yesterday. So, now you’re tripling your revenue. I didn’t feel that it was strategically the message they really wanted to send for the company because it puts them under pressure to have increasing amounts of revenue in a market that’s still very nascent. I felt that it was a stupid move because they’re setting expectations that the revenue is going to really grow and ramp, and it’s not. — Former executive of IonQ"

""WaterSound, located on approximately 1,402 acres and currently planned for a 1,330-unit mixed-use development, is a resort community approximately three miles from WaterSound Beach north of U.S. 98 in Walton County. WaterSound land-use entitlements include 457,380 square feet of commercial space. The DRI process for WaterSound was completed in 2005. This resort town is being planned for the pre-retirement and second-home markets with six and nine-hole golf courses along with pools, beach access and other amenities. Sales at WaterSound are expected to begin in mid-2006." — JOE 2005 10-K, p.6"

""Expected average member count for the fourth quarter to 4.6 million." -- Mark Livingston, 3Q22 Transcript; "We continued that momentum and secured a record 105 new client commitments during the selling season representing an additional 1.2 million covered lives."; "Weighted average covered lives increased by more than 200,000 [in 3Q22] driven by the launch of nine new clients at various points during the quarter." -- Mark Livingston, 3Q22 Transcript; "We expect to be managing fertility benefits for 5.4 million people and approximately 370 companies in 2023" -- Peter Anevski, 3Q22 Transcript"

""We are exercising caution around the industry's recent acceleration of the direct selling or door-to-door sales channels through independent sales dealers." — Lynn Michelle Jurich, CEO of Sunrun, Q4 2019 Earnings Call. "I would suspect that our direct will take share versus the pre-COVID for all those reasons that the market leaders, I think, will take share generally." — Lynn Michelle Jurich, CEO of Sunrun, Q1 2020 Earnings Call. "we expect those channels to continue to grow faster than our direct-to-home and dealer channels" — David H. Bywater, CEO of Vivint Solar, Q4 2019 Earnings Call."

""But we've been able to branch out and the demand, I think, on the retail side has really been energizing for all of us, whether it be CVS or Walgreens or Walmart or GMC, Bed Bath & Beyond, Vitamin Shoppe. I mean there's just an incredible demand for the products and those retailers are coming to us with an energy that I think is very rare." — CEO Dudum on Q4 2021 Earnings Call; "As we have previously communicated, we expect revenue growth in our wholesale channel to moderate as we now have a presence in the majority of top retailers across the country." — CEO Dudum on Q4 2022 Earnings Call"

""Based in Los Angeles, Vubiquity is a provider of premium content services and technology solutions, which upon closing, we expect will contribute annualized revenue of approximately $100 million for Amdocs." — Eli Gelman, President and CEO, Amdocs; "During Q1, to support our digital strategy, we acquired projekt202... the revenue contribution for the quarter was immaterial." — Tamar Rapaport-Dagim, CFO, Amdocs; "And in terms of the numbers, [UXP is] less material. So, that's why we didn't refer to it. It's relatively a small company at this stage..." — Tamar Rapaport-Dagim, CFO, Amdocs."

""...the strategic infrastructure we have in North Dakota, having control of that adds a lot of value...that's not something we would be interested in MLPing...Energy Marketing and Retail Marketing remain a long-term strategic part of our portfolio that...builds upon our strong brand..." — John Hess, November 2012; "...monetization of our Bakken midstream assets expected in 2015...We have had this strategic transformation underway really...predominately when we started to build our Bakken position in 2010. So this is not something that just happened overnight..." — John Hess, March 2013"

"“Fashion Show is a little bit of a different situation. The income there continues to grow very significantly, well ahead of our comp NOI average, and we expect that to continue. There are other things that we've been telling people for years that we're trying to get done there, including getting a certain portion of the project land in the Northeast corner under control, where we might be able to do additional development of that site, given its highly lucrative location right on the strip. So we wanted that flexibility.” — Bernie Freibaum, Former CFO of GGP, Q1’08 earnings transcript"

"So, the attempt -- I'm going to go back to the beginning of this -- so the attempt of Herbalife 101 was to break the distributors into single and multilevel. Why? Because A, it is truly single, and B, nobody questions single-level, knowing that most people who are in single-level aren't in it to make a lot of money. They are either in it for part time or it is self-consumption. If you go back to the old Avon model, before they were multilevel, right, self-consumption, not even an issue. It isn't not even covered on the FTC's website. It is expected. — John DeSimone, CFO, Herbalife Ltd."

""Invisalign has diluted the orthodontic industry. They took away our exclusivity. The damage is done now.... We just don't trust Invisalign.... It is just a matter of time that I move as much of my case volume as possible away from Invisalign." — Orthodontist, Diamond Plus Align Tier; "I expect my Invisalign volumes to be down going forward. Direct to Consumer offerings are taking business away from us." — Orthodontist, Diamond Plus Align Tier; "If I had to guess 30% to 40% of SDC cases are cases that would have gone to Invisalign if the DTC option was not available." — Dentist, DSO"

""This quarter, we reported a positive gross margin of $1.8 million, and we expect to continue to improve our operational synergies..." — Leproust, April 30, 2019 press release. "In addition, we delivered continued improvements in our gross margin, which increased to 16 percent of revenue in the third quarter..." — Jim Thorburn, CFO of Twist, Aug 1, 2019 press release. "We posted a positive 21% gross margin for the fiscal 2019 fourth quarter and 13% for the full year as our revenue scaled and we leveraged our cost structure," — Jim Thorburn, CFO of Twist, Dec 11, 2019 press release."

"I think your second question was on our final landing for 2015 and versus what could have been a previous assumption around the middle of the year. What is true is that the mild conditions in the fall have been negative for all the textile sales that we have in some of our stores. Our vision is nevertheless that we performed better than specialized retailers in textile. You probably have more data than us on that front and you might have heard that most of the specialized retailers have had a very tough time. But we did a little below our initial expectation. — Giscard d'Estaing"

""You know, people have said that IonQ is like, buying into Intel in the early days. I think it’s actually closer to Nvidia, you know." — Peter Chapman, Absolute Return Podcast. "Well you know, quantum computing many people expect that quantum computers will be able to solve many of mankind's kind of grand challenges, everything from direct carbon capture, to new drug discovery, new batteries, solving strong AI, improving machine learning. Since we're talking about just a much bigger computer, it's kind of hard to say where it won't be used." — Peter Chapman, YouTube interview."

""So from the standpoint of pricing, the pricing environment, I would say, hasn't changed much in the last 90 days since we spoke last. And quite honestly, I don't expect that the consolidation that has happened will have much of an impact on the pricing environment." — Cintas CFO Response. "In terms of what we're seeing in the market right now, we're seeing some of that disruption... If you're sitting at the table with a national account... it can lead to challenges and one of those competitors potentially coming in with a very aggressive offer." — CEO Unifirst Steven Sintros."

"“Retail leasing activity increased significantly in the first quarter of 2010, with total in-line and outparcel tenant leasing deals covering 1.36 million square feet signed, an increase of 21% over the same period of last year. Within total deals, the number of new lease deals grew 84%, representing new deal square footage of approximately 284 thousand square feet. Although rents remain below 2007 peak levels, they have stabilized. As sales continue their upward trend, the Company expects lease rates to reflect those increases over time.” — GGP Q1’10 Operating Supplement"

"“And what's interesting, when you promote people into new jobs or bring in new talent from outside, how you get increasingly different insights into how we operate our business. Adding these people and promoting these people are making us a better company. They're raising the bar in terms of the excellence that we expect of ourselves and we expect of our staff. And it is in fact permeating the entire organization. As new people come in with new ideas and raise the expectations, it's helping us better perform as a company.” — Gerald Hassell, CEO 10/28/14 Investor Day"

""Closed sales represent an estimate of the expected annual recurring fee revenue for new client contracts that were signed by Broadridge in the current reporting period. Management uses Closed sales to measure the effectiveness of our sales and marketing programs, as an indicator of expected future revenues and as a performance metric in determining incentive compensation...Larger Closed sales can take up to 12 to 24 months or longer to convert to revenues, particularly for the services provided by our Global Technology and Operations segment." — 2019 Annual Report"

"The valuer used the Residual Value Approach for the valuation of the investment property under development. In order to assess the market value of the sites, the valuer undertook a development appraisal to assess the potential value (Gross Development Value) of the fully completed and leased development as currently proposed, and deducted hard costs, soft costs, financing costs and a developer's expected required profit (which reflects the required level of return to a developer and the risk of undertaking the project). — CPIPG 2023 management report, p. 117"

"In late 2017 two institutions, the Mayo Clinic, Rochester and UCLA, secured IRB approval to conduct a randomized clinical trial investigating the efficacy and associate health economic outcomes of Pheno.... Regardless, the study is nearing completion, and we expect enrollment to finish in Q3 with early data soon after. If this study concludes as we hope it will demonstrate the improved outcome for these critically ill patients with positive impact on mortality and morbidity length of stay stewardship and cost. We can't wait. — Mehren (Q1 2018 Earnings Call)"

""Restricted stock units were also granted on an off-cycle basis to Mr. Boehnlein and Mr. Menon in May 2021 and to Mr. Pierce and Mr. Stiles in October 2021... awarded in recognition of their efforts and contributions related to the Company's cost transformation initiative" — Stryker Proxy Statement. "And so we haven't seen anything really show up in terms of any major impacts on our financials... we expect gross margin performance to be negatively impacted by 50 to 100 basis points" — CFO and IR Q3 and Yr End Call Conf Calls and Cowen Conf March 11th 2022."

"And the class of '20 and class of 2021 are the best class of stores we've ever opened. — CFO Lang, GS Conf. Sept 8, 2022; And so that's part of the reason our CapEx costs are going up is because we're doing more of that. — CFO Lang, Stephens Conf. Dec 2, 2021; Based on challenging macroeconomic conditions, our class of 2022 and class of 2023 new stores are estimated to be below these targets. — 2023 10-K, Feb 22, 2024; We expect about 25% to 30% of our planned 2024 new warehouse store openings could be in smaller format stores. — Q4'23 Conf Call, Feb 2024"

""In the first quarter of 2020, we adopted, using the modified retrospective approach, amended accounting guidance that required credit losses on financial instruments, including trade receivables, to be measured based on an expected credit loss model instead of the incurred loss model. The expected credit loss model requires us to consider forward-looking information to estimate our allowance for credit losses. Our adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows." — 2020 10-Q, p. 6"